{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:10:17Z","timestamp":1756368617378,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ensci.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T17:56:05Z","timestamp":1469037365000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data"],"prefix":"10.1016","volume":"5","author":[{"given":"Hsin Fen","family":"Chien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lucia Zuma de","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Sobierajski dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Roberto de Mello","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora Palma","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delson Jos\u00e9 da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio da Cunha","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Vinicius Della","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Desterro Leiros da","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto C\u00e9sar Pereira do","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-2757","authenticated-orcid":false,"given":"Vanderci","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor","family":"Tumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner de Goes","family":"Horta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ensci.2016.07.001_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.ensci.2016.07.001_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1590\/S0004-27492005000400010","article-title":"Botulinum toxin in the treatment of facial dystonia: evaluation of its efficacy and patients' satisfaction along the treatment","volume":"68","author":"Costa","year":"2005","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.ensci.2016.07.001_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-160X-4-5","article-title":"The use of botulinum toxin in head and face medicine: an interdisciplinary field","volume":"4","author":"Laskawi","year":"2008","journal-title":"Head Face Med"},{"issue":"5","key":"10.1016\/j.ensci.2016.07.001_bb0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/S0004-282X2011000600004","article-title":"Botulinum toxin type A and cervical dystonia: a seven-year follow-up","volume":"69","author":"Camargo","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.ensci.2016.07.001_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/14740338.4.2.241","article-title":"The safety and tolerability of botulinum toxins for the treatment of cervical dystonia","volume":"4","author":"Brashear","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0030","first-page":"30","article-title":"Dystonias: clinical and therapeutic aspects in 64 patients","volume":"54","author":"De Mattos","year":"1996","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2A","key":"10.1016\/j.ensci.2016.07.001_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0004-282X2005000200006","article-title":"Botulinum toxin a in the treatment of blepharospasm: a 10-year experience","volume":"63","author":"Silveira-Moriyama","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3-A","key":"10.1016\/j.ensci.2016.07.001_bb0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1590\/S0004-282X1995000300006","article-title":"Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients","volume":"53","author":"Novis","year":"1995","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.WNF.0000236771.77021.3C","article-title":"A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm","volume":"30","author":"Rieder","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S0004-282X2008000100005","article-title":"Cervical dystonia: clinical and therapeutic features in 85 patients","volume":"66","author":"Camargo","year":"2008","journal-title":"Arq. Neuropsiquiatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ensci.2016.07.001_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13","author":"Bhidayasiri","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.ensci.2016.07.001_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0004-282X2012000600005","article-title":"Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A","volume":"70","author":"Teive","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ensci.2016.07.001_bb0065","first-page":"232","article-title":"Tratamento de discinesia bucoorolingual tardia com toxina botul\u00ednica tipo A (TOXBA): registro de caso com v\u00eddeo. XX Congresso Brasileiro de Neurologia, 2002, Florian\u00f3polis","volume":"60","author":"Silva","year":"2002","journal-title":"Arq. Neuropsiquiatr."},{"issue":"9","key":"10.1016\/j.ensci.2016.07.001_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archotol.127.9.1083","article-title":"Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia","volume":"127","author":"Benninger","year":"2001","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0075","first-page":"39","article-title":"Voice related quality of life after botulinum toxin injection for spasmodic dysphonia","volume":"131","author":"Gama","year":"2010","journal-title":"Rev. Laryngol. Otol. Rhinol."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2009.06.004","article-title":"Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients","volume":"16","author":"Maia","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.ensci.2016.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/WNL.50.5.1461","article-title":"Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia","volume":"50","author":"Brans","year":"1998","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ensci.2016.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/mds.20670","article-title":"Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia","volume":"20","author":"Skogseid","year":"2005","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.ensci.2016.07.001_bb0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin: mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"author":"Datasus","key":"10.1016\/j.ensci.2016.07.001_bb0100"},{"issue":"2","key":"10.1016\/j.ensci.2016.07.001_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00002508-200503000-00010","article-title":"Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia","volume":"21","author":"Allam","year":"2005","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.ensci.2016.07.001_bb0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.20836","article-title":"Myelopathy as a complication of cervical dystonia","volume":"21","author":"Spitz","year":"2006","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.ensci.2016.07.001_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/0004-282X20140044","article-title":"The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia","volume":"72","author":"Werle","year":"2014","journal-title":"Arq. Neuropsiquiatr."},{"issue":"6","key":"10.1016\/j.ensci.2016.07.001_bb0120","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1590\/S0004-282X2011000700010","article-title":"Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital","volume":"69","author":"Queiroz","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.ensci.2016.07.001_bb0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3111\/13696998.2011.653726","article-title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","volume":"15","author":"Sethi","year":"2012","journal-title":"J. Med. Econ."},{"issue":"8","key":"10.1016\/j.ensci.2016.07.001_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","article-title":"Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm","volume":"13","author":"Ochudlo","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"14","key":"10.1016\/j.ensci.2016.07.001_bb0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves","year":"2012","journal-title":"Mov. Disord."},{"author":"Instituto Brasileiro de Geografia e Estat\u00edstica","key":"10.1016\/j.ensci.2016.07.001_bb0140"}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650216300260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650216300260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:43:31Z","timestamp":1756367011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650216300260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"alternative-id":["S2405650216300260"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2016.07.001","relation":{},"ISSN":["2405-6502"],"issn-type":[{"type":"print","value":"2405-6502"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}